| Released | Contributor | Author | Title | Pages | Price | | 29-Nov-2009 | Freedonia Group Inc, The | The Freedonia Group | Freedonia Focus on Cancer Therapies | 23 |
$500 | | 29-Nov-2009 | Freedonia Group Inc, The | The Freedonia Group | Freedonia Focus on Nutraceutical Ingredients | 20 |
$500 | | 23-Nov-2009 | Stock Traders Daily | Thomas H. Kee Jr. | Trading Report for (PFE). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (PFE). | 5 |
$18 | | 23-Nov-2009 | Reuters Investment Profile |
N/A
| Pfizer Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 | | 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 | | 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 | | 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Market Research and Competitive Analysis 2010 | 730 |
$299 | | 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Plunkett's Health Care Technologies Overview 2010 (Summary) | 80 |
$199 | | 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Trends, Statistics & Analysis 2010 (Summary) | 98 |
$199 | | 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Engineering & Research Industry Trends, Statistics & Analysis 2009 (Summary) | 70 |
$199 |
|
1.29% Nasdaq 0.00%
Research Reports
